vs
Side-by-side financial comparison of Expensify, Inc. (EXFY) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $35.2M, roughly 1.2× Expensify, Inc.). On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -4.9%). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 2.4%).
Expensify, Inc. is a software company that develops an expense management system for personal and business use. Expensify also offers a business credit card called the Expensify Card.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
EXFY vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $41.8M |
| Net Profit | — | $-7.2M |
| Gross Margin | 49.2% | 52.0% |
| Operating Margin | -11.2% | -12.1% |
| Net Margin | — | -17.2% |
| Revenue YoY | -4.9% | 85.7% |
| Net Profit YoY | — | 43.2% |
| EPS (diluted) | $-0.07 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $41.8M | ||
| Q3 25 | $35.1M | $37.3M | ||
| Q2 25 | $35.8M | $38.1M | ||
| Q1 25 | $36.1M | $32.0M | ||
| Q4 24 | $37.0M | $22.5M | ||
| Q3 24 | $35.4M | $18.5M | ||
| Q2 24 | $33.3M | $16.4M | ||
| Q1 24 | $33.5M | $17.4M |
| Q4 25 | — | $-7.2M | ||
| Q3 25 | $-2.3M | $-9.0M | ||
| Q2 25 | $-8.8M | $-10.1M | ||
| Q1 25 | $-3.2M | $-12.7M | ||
| Q4 24 | — | $-12.7M | ||
| Q3 24 | $-2.2M | $-13.3M | ||
| Q2 24 | $-2.8M | $-9.8M | ||
| Q1 24 | $-3.8M | $-7.9M |
| Q4 25 | 49.2% | 52.0% | ||
| Q3 25 | 49.6% | 45.9% | ||
| Q2 25 | 51.9% | 46.6% | ||
| Q1 25 | 50.6% | 49.2% | ||
| Q4 24 | 51.0% | 66.2% | ||
| Q3 24 | 51.6% | 75.6% | ||
| Q2 24 | 56.9% | 74.0% | ||
| Q1 24 | 56.5% | 75.1% |
| Q4 25 | -11.2% | -12.1% | ||
| Q3 25 | -6.4% | -19.6% | ||
| Q2 25 | -28.9% | -21.1% | ||
| Q1 25 | -4.1% | -34.4% | ||
| Q4 24 | 1.3% | -51.0% | ||
| Q3 24 | 0.8% | -41.7% | ||
| Q2 24 | 0.7% | -51.7% | ||
| Q1 24 | -5.3% | -39.4% |
| Q4 25 | — | -17.2% | ||
| Q3 25 | -6.6% | -24.3% | ||
| Q2 25 | -24.6% | -26.6% | ||
| Q1 25 | -8.8% | -39.6% | ||
| Q4 24 | — | -56.4% | ||
| Q3 24 | -6.2% | -72.0% | ||
| Q2 24 | -8.3% | -59.8% | ||
| Q1 24 | -11.3% | -45.2% |
| Q4 25 | $-0.07 | $-0.10 | ||
| Q3 25 | $-0.03 | $-0.13 | ||
| Q2 25 | $-0.10 | $-0.15 | ||
| Q1 25 | $-0.03 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.34 | ||
| Q3 24 | $-0.02 | $-0.44 | ||
| Q2 24 | $-0.03 | $-0.33 | ||
| Q1 24 | $-0.04 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.1M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $132.7M | $22.4M |
| Total Assets | $186.0M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.1M | $28.1M | ||
| Q3 25 | $61.5M | $28.0M | ||
| Q2 25 | $60.5M | $11.0M | ||
| Q1 25 | $59.6M | $20.2M | ||
| Q4 24 | $48.8M | $18.5M | ||
| Q3 24 | $39.2M | $20.9M | ||
| Q2 24 | $53.2M | $42.6M | ||
| Q1 24 | $49.3M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | $132.7M | $22.4M | ||
| Q3 25 | $135.7M | $27.4M | ||
| Q2 25 | $131.8M | $27.1M | ||
| Q1 25 | $134.7M | $35.5M | ||
| Q4 24 | $128.2M | $27.7M | ||
| Q3 24 | $119.9M | $9.4M | ||
| Q2 24 | $114.0M | $19.4M | ||
| Q1 24 | $106.5M | $27.7M |
| Q4 25 | $186.0M | $141.6M | ||
| Q3 25 | $186.8M | $145.5M | ||
| Q2 25 | $187.1M | $134.7M | ||
| Q1 25 | $189.2M | $142.0M | ||
| Q4 24 | $173.7M | $140.9M | ||
| Q3 24 | $176.2M | — | ||
| Q2 24 | $192.9M | $96.8M | ||
| Q1 24 | $184.8M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2M | $908.0K |
| Free Cash FlowOCF − Capex | — | $692.0K |
| FCF MarginFCF / Revenue | — | 1.7% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $908.0K | ||
| Q3 25 | $4.2M | $-785.0K | ||
| Q2 25 | $8.9M | $-3.5M | ||
| Q1 25 | $4.8M | $-17.0M | ||
| Q4 24 | $7.4M | $-8.6M | ||
| Q3 24 | $3.7M | $-5.4M | ||
| Q2 24 | $9.3M | $-5.0M | ||
| Q1 24 | $3.5M | $-12.0M |
| Q4 25 | — | $692.0K | ||
| Q3 25 | — | $-899.0K | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-17.2M | ||
| Q4 24 | — | $-8.7M | ||
| Q3 24 | — | $-5.8M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-12.4M |
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | -9.9% | ||
| Q1 25 | — | -53.8% | ||
| Q4 24 | — | -38.6% | ||
| Q3 24 | — | -31.3% | ||
| Q2 24 | — | -34.0% | ||
| Q1 24 | — | -71.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.0% | 2.1% | ||
| Q2 24 | 0.0% | 3.7% | ||
| Q1 24 | 0.0% | 2.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
